Vinay Nair
Overview
Explore the profile of Vinay Nair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
487
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pagan Santini R, Bhaskaran M, Nair V, Nair G, Fahmy A
Cureus
. 2025 Feb;
17(1):e77154.
PMID: 39925577
Kidney transplantation is the preferred treatment for end-stage renal disease, but it involves risks, including an increased chance of malignancy due to several variables. We present a rare case of...
2.
Chandraker A, Regmi A, Gohh R, Sharma A, Woodle E, Ansari M, et al.
J Am Soc Nephrol
. 2024 Mar;
35(5):618-629.
PMID: 38470444
No abstract available.
3.
Jandovitz N, George S, Abate M, Kressel A, Bolognese A, Lau L, et al.
Clin Transplant
. 2023 Sep;
37(12):e15139.
PMID: 37725341
Introduction: This study examines whether the use of inpatient Continuous Glucose Monitors provides improved glycemic control over finger-stick glucose monitoring post-transplant. Methods: This is a single-site, prospective randomized controlled trial...
4.
Hirsch J, Jhaveri K, Abate M, Molmenti E, Coppa K, Nair V
Clin Nephrol
. 2023 Jun;
100(3):140-142.
PMID: 37366556
No abstract available.
5.
Murakami N, Webber A, Nair V
Adv Chronic Kidney Dis
. 2022 Jul;
29(2):188-200.e1.
PMID: 35817526
Cancer is a leading cause of death in patients with kidney transplantation. Patients with kidney transplants are 10- to 200-times more likely to develop cancers after transplant than the general...
6.
Ng J, Izard S, Murakami N, Jhaveri K, Sharma A, Nair V
Nephrol Dial Transplant
. 2022 Jun;
37(12):2569-2580.
PMID: 35687020
Background: Recent improvement in treatment and patient survival has opened the eligibility of kidney transplantation to patients who developed end-stage kidney disease (ESKD) from plasma cell dyscrasias (PCDs). Data on...
7.
Abate M, Jandovitz N, Hirsch J, Breslin N, Lau L, Fahmy A, et al.
Clin Kidney J
. 2022 May;
15(5):942-950.
PMID: 35498880
Background: Race coefficients of estimated glomerular filtration rate (eGFR) formulas may be partially responsible for racial inequality in preemptive listing for kidney transplantation. Methods: We used the Scientific Registry of...
8.
Nair G, Nair V
Clin Liver Dis
. 2022 Apr;
26(2):313-322.
PMID: 35487613
End-stage kidney disease (ESKD) after liver transplantation is associated with high morbidity and mortality. This increase in mortality can be offset by performing a kidney transplant at the time of...
9.
Fishbane S, Hirsch J, Nair V
Am J Kidney Dis
. 2022 Jan;
79(4):480-482.
PMID: 35032591
No abstract available.
10.
Koulgi S, Jani V, Nair V, Saini J, Phukan S, Sonavane U, et al.
J Biomol Struct Dyn
. 2021 Jan;
40(13):5996-6012.
PMID: 33494645
Evaluation of cardiotoxicity potential of new chemical entities (NCEs) has lately become one of the stringent filters in the drug discovery and development process. Cardiotoxicity is caused mainly by the...